Mariko Wakayama

EpCAM‐ and EGFR‐targeted selective gene therapy for biliary cancers using Z33‐fiber‐modified adenovirus

I. Hyodo, H. Mizuguchi, Y. Obata, 2011, International journal of cancer.

E1A, E1B Double-Restricted Adenovirus with RGD-Fiber Modification Exhibits Enhanced Oncolysis for CAR–Deficient Biliary Cancers

I. Hyodo, N. Tanaka, H. Hamada, 2007, Clinical Cancer Research.

Effective gene therapy of biliary tract cancers by a conditionally replicative adenovirus expressing uracil phosphoribosyltransferase: significance of timing of 5-fluorouracil administration.

N. Tanaka, Y. Matsuzaki, H. Hamada, 2005, Cancer research.

5-Fluorouracil Administration Phosphoribosyltransferase : Significance of Timing of Conditionally Replicative Adenovirus Expressing Uracil Effective Gene Therapy of Biliary Tract Cancers by a

N. Tanaka, Y. Matsuzaki, H. Hamada, 2005 .

E1A, E1B double-restricted adenovirus for oncolytic gene therapy of gallbladder cancer.

N. Tanaka, H. Hamada, K. Yokoyama, 2003, Cancer research.

E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer

I. Hyodo, H. Hamada, K. Yokoyama, 2009, Cancer Gene Therapy.